• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR (P55); INTRAVASCULAR ADMINISTRATION SET

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BECTON DICKINSON, S.A. BD PHASEAL¿ PROTECTOR (P55); INTRAVASCULAR ADMINISTRATION SET Back to Search Results
Catalog Number 515117
Medical Device Problem Code Break (1069)
Health Effect - Clinical Code No Clinical Signs, Symptoms or Conditions (4582)
Date of Event 02/21/2023
Type of Reportable Event Malfunction
Additional Manufacturer Narrative
A device evaluation is anticipated but has not yet begun.Upon completion of the investigation, a supplemental report will be filed.
 
Event or Problem Description
It was reported that 15 bd phaseal¿ protectors (p55) had issues with broken spikes found before the drug preparation.The following information was provided by the initial reporter: "in the medical oncology - before the drug preparation.It was observed that the spike of the protector was broken when the vials were opened for capping with the protector.".
 
Event or Problem Description
It was reported that 15 bd phaseal¿ protectors (p55) had issues with broken spikes found before the drug preparation.The following information was provided by the initial reporter: "in the medical oncology - before the drug preparation.It was observed that the spike of the protector was broken when the vials were opened for capping with the protector.".
 
Additional Manufacturer Narrative
The following fields were updated due to additional information: d10: device available for eval yes, returned to manufacturer on: 06-mar-2023.H6: investigation summary: three unused samples, the impacted product, and two photos were provided to our quality team for investigation.Through visual inspection of the photos and reported device, the tip of the protector spike is observed to be bent, verifying the reported incident.A device history review was performed for the reported lot 2204113, no deviations or non-conformances were identified during the manufacturing process that could have contributed to this incident.Three retained samples of the same lot were used for additional evaluation.The retained samples along with the unused product returned were inspected and no damage to the protector spikes was observed.Final products in this manufacturing line, for this reference are sampled and they are subjected to visual and functional inspections during the different manufacturing sub-processes according to procedures.While we could not identify a direct issue, it was determined the damage likely occurred during the assembly process when the piece moved between machines.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BD PHASEAL¿ PROTECTOR (P55)
Common Device Name
INTRAVASCULAR ADMINISTRATION SET
Manufacturer (Section D)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer (Section G)
BECTON DICKINSON, S.A.
camino de valdeolivia
s/n
san agustin de guadalix
Manufacturer Contact
phillip emmert
9450 south state street
sandy, UT 84070
8448235433
MDR Report Key16546831
Report Number3003152976-2023-00069
Device Sequence Number12272599
Product Code ONB
UDI-Device Identifier00382905151170
UDI-Public00382905151170
Combination Product (Y/N)N
Initial Reporter CountryTU
PMA/510(K) Number
K123213
Number of Events Summarized1
Summary Report (Y/N)N
Serviced by Third Party (Y/N)N
Reporter Type Manufacturer
Report Source Other,Foreign,User Facility
Initial Reporter Occupation Other Health Care Professional
Type of Report Initial,Followup
Report Date (Section B) 03/28/2023
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Operator of Device Other
Device Catalogue Number515117
Device Lot Number2204113
Was Device Available for Evaluation? Device Returned to Manufacturer
Is the Reporter a Health Professional? Yes
Type of Report(Section G)Thirty-Day
Initial Date Received by Manufacturer 02/22/2023
Supplement Date Received by Manufacturer03/28/2023
Initial Report FDA Received Date03/15/2023
Supplement Report FDA Received Date04/04/2023
Was Device Evaluated by Manufacturer? (Y/N) Yes
Date Device Manufactured04/22/2022
Is the Device Labeled for Single Use? (Y/N) Yes
Is This a Single-Use Device that was
Reprocessed and Reused on a Patient? (Y/N)
No
Usage of Device Initial
Patient Sequence Number1
Patient SexUnknown
-
-